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Department of Cellular and Molecular Medicine, Center for Peptide-Based Antibiotics, The Panum Institute, Faculty of Health
and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Peptide Nucleic Acid (PNA)-peptide conjugates targeting essential bacterial genes
are showing promise as antisense antimicrobials in drug discovery. Optimization has
focused on selection of target genes and exact localization around the ribosome binding
site, but surprisingly a length optimum around 10–12 nucleobases has been found.
Addressing this observation, we have investigated the relationship between PNA-length,
PNA–RNA duplex stability and antimicrobial activity in E. coli in more detail. For PNAs
of identical length of ten nucleobases the expected reverse correlation between the
thermal stability (Tm) of the PNA–RNA duplex and the MIC for single mismatched
PNAs was found. Also the expected direct correlation between the length of the PNA
and the PNA–RNA duplex stability was found. Nonetheless, 10-mer PNAs [in a 6–
18 mer extension series of (KFF)3K- and (RXR)4 conjugates] were the most active as
antisense antimicrobials in both wild type E. coli MG1655 and AS19, suggesting that
the size constraint is related to the bacterial uptake of PNA-peptide conjugates. This
conclusion was supported by flow cytometry data showing higher bacterial uptake of
shorter PNA fluorophore labeled conjugates. Interestingly, the size-limited uptake seems
independent on outer membrane integrity (AS19), and thus the results suggest that the
inner membrane limits the molecular size for peptide-PNA passage.
Keywords: antisense antimicrobials, peptide nucleic acid, peptide conjugates, bacterial envelope,
Escherichia coli
INTRODUCTION
The extensive use of antibiotics in the past half century has given rise to development of antibiotic
resistant bacterial strains by a variety of mechanisms. Recently, the threat to global human health
from multi-drug-resistant bacterial infections has emphasized the urgent need for discovery of new
classes of antibiotics with novel molecular targets and mechanism of action. Effective antibiotics
are characterized by their specificity for bacteria and thus low toxicity toward mammalian cells.
Antibiotics working via an antisense mechanism, targeting essential bacterial genes is one way
of ensuring high specificity. Peptide nucleic acids (PNAs) are particularly well-suited as such
antimicrobial antisense agents because of their resistance to nucleases and proteases as well as
favorable sequence specific RNA hybridization properties, although bacterial uptake is a general
challenge in the application of PNAs (and of oligonucleotides and their analogs and mimics in
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general) as antisense agents. However, conjugation to bacteria
penetrating peptides (BPPs) was discovered as a successful way to
ensure increased PNA uptake and thereby efficacy (Good et al.,
2001). Specifically, the (KFF)3K peptide conjugated to a PNA
targeting the essential bacterial gene, acpP, was shown to be
sequence specifically bactericidal against Escherichia coli (Good
et al., 2001). Subsequently, antibacterial effects of peptide-PNA
[and also of phosphordiamidate morpholino oligomer (PMO)
(Geller et al., 2018)] conjugates against a range of antibiotic
resistant bacterial species have been reported, e.g., multi-resistant
Klebsiella pneumoniae (Kurupati et al., 2007) and Haemophilus
influenzae (Otsuka et al., 2017), and Pseudomonas aeruginosa
(Montagner et al., 2017) in planktonic cultures as well as biofilms.
Furthermore, recent studies have identified the inner-membrane
SbmA protein as a necessary transporter of some peptide-PNA
conjugates (Ghosal et al., 2013). However, other carrier peptides
do not require SbmA for activity, and SbmA is therefore not the
only mechanism of transport across the inner membrane (Ghosal
et al., 2013; Hansen et al., 2016).
Antisense efficacy relies on high sequence specific affinity for
the mRNA target, and the strongest antisense effect is achieved
by targeting sequences around and proximally upstream of
the translation start codon (Dryselius et al., 2003). In general,
increased efficacy with increased RNA target affinity, and thus
length to a first approximation, is expected. However, early
studies have surprisingly revealed an optimum PNA (and PMO)
size of 10–12 nucleobases for antimicrobial antisense agents
(Good et al., 2001; Deere et al., 2005).
It is worth noting that – analogously to the situation in
eukaryotic cells – antisense agents may exert their activity via
different mechanisms, broadly operating by mRNA degradation
via RNaseH activation or by steric blockage of mRNA translation
or processing. Antisense targeting in bacteria have almost
exclusively been performed using PNA and PMO oligomers
which do not activate RNaseH and therefore appear to work
primarily through translation inhibition, although some reports
do also indicate that mRNA decay (possibly induced by
translation blockage) may result. RNA silencing occurs naturally
in bacteria and these pathways may eventually also be exploited
for RNA targeted antibiotic discovery (Soler Bistué et al., 2009;
Good and Stach, 2011; Lopez et al., 2015).
In this study we have more systematically investigated the
influence of PNA-length on the antimicrobial effect in E. coli
using a series of peptide-PNA antibacterial antisense agents
targeting acpP through translation inhibition with the aim of
elucidating the mechanism behind the puzzling PNA length
limitation. This was done for different carrier peptides, in
different E. coli strains and in the presence or absence of the
SbmA inner membrane transporter.
MATERIALS AND METHODS
Strains and PNAs
Escherichia coli strains MG1655, MG1655(1sbmA) (Ghosal et al.,
2013), AS19 (Sekiguchi and Iida, 1967), ATCC25922(1rfaG)
(Ebbensgaard et al., 2018), and Klebsiella pneumoniae ATCC
13883 were used throughout the study and cultured in non-cation
adjusted Muller-Hinton Broth (MHB) (Sigma-Aldrich, cat.no.
70192) at 37◦C.
Peptide nucleic acids (Table 1) were dissolved in water and the
concentration determined using a NanoDrop spectrophotometer
at 260 nm. Low binding plastics (Axygen, Corning) were
used throughout.
Tm Determination
Thermal stability (Tm) measurements were performed on a
Cary 300 Bio UV-visible spectrophotometer (Varian, Cary, NC,
United States) connected to a temperature controller. Thermal
melting profiles were obtained in 10 mM Na-phosphate (pH
7.0) containing 0.1 mM EDTA and 100 mM NaCl using a
heating range of 5–95◦C at a rate of 0.5oC/min. The melting
temperature (Tm) was determined from the maximum of the
first derivative of the heating curve. Cuvettes of 1.0 cm path
length and 1.0 ml volume were used for all experiments. RNA
oligonucleotide 5089: 5’-AGA GUA UGA GCA CUA UCG-3’ was
used for all Tm experiments.
MIC Determination
MIC values were determined by broth microdilution according
to standard protocols with a few modifications (Cockerill
et al., 2012). An overnight bacterial cell culture was diluted to
approximately 5 × 10E5 CFU/ml in non-cation-adjusted MHB.
190 ul bacterial solution was dispensed into a low-bind 96-well
plate (Thermo-Scientific, cat.no. 260895) along with 10 ul of
the test compound. The plate was incubated in a Tecan Genios
plate reader at 37◦C for 18 h with linear shaking, OD was
measured every 20 min at 595 nm. The MIC was determined as
the lowest concentration, which inhibited visible growth in the
wells (OD(595 nm)< 0.1).
Spheroplast Preparation
Escherichia coli cells were cultured in MHB overnight, diluted
to OD(595 nm) = 0.3 and incubated at 37◦C with shaking
for 1–2 h. E. coli cells were harvested in exponential phase
at 7000 g, 8 min at 4◦C, washed twice in 0.01M Tris–HCl,
pH 7.4 and then resuspended in the same buffer containing
0.5M sucrose. Then lysozyme was added to the cell suspension
at a final concentration of 150 µg/ml and EDTA was added
to a final concentration of 10 mM. This suspension was
incubated overnight in a water bath at 37◦C. Spheroplasts
were gently washed three times in 0.01 M Tris–HCl with
0.5 M sucrose (Birdsell and Cota-Robles, 1967). Spheroplasts
were incubated with peptide-PNA for 2 h, serially diluted
with 0.5 M sucrose in 0.01 M Tris–HCl, pH 7.4, plated
on LB agar plates, and colonies were counted after over-
night incubation.
Flow Cytometry
Escherichia coli cells were cultured in MHB overnight and diluted
100× into fresh media and grown to exponential phase at
OD595 = 0.2. The cells were pelleted and re-suspended (to a 100×
dilution) in PBS buffer containing the PNA, and then incubated
for 1 h at room temperature. The cell suspension was diluted five
times in PBS and profiled using an Apogee Flow Cytometer A10.
Frontiers in Microbiology | www.frontiersin.org 2 May 2019 | Volume 10 | Article 1032
fmicb-10-01032 May 22, 2019 Time: 17:2 # 3
Goltermann et al. Antisense PNA-Peptide Antibacterials Length Dependence
TABLE 1 | Peptide-PNA-conjugates used (mm = mismatch).
PNA Peptide PNA sequence Length Target
2301 – CTC ATA CTC T 10 acpP
4223 – TG CTC ATA CTC T 12 acpP
4224 – A GTG CTC ATA CTC T 14 acpP
4226 – CG ATA GTG CTC ATA CTC T 18 acpP
3961 – CTC TTA CAC T 10 mm for PNA2301
4521 – TG CTC TTA CAC T 12 mm for PNA4223
4522 – A GTG CTC TTA CAC T 14 mm for PNA4224
4524 – CG ATA GTG CTC TTA CAC T 18 mm for PNA4226
4720 H-(KFF)3K-eg1- CACATACTCT 10 mm for PNA2108
4721 H-(KFF)3K-eg1- CTCTTACTCT 10 mm for PNA2108
4722 H-(KFF)3K-eg1- CTCATAGTCT 10 mm for PNA2108
4723 H-(KFF)3K-eg1- CTCATACTGT 10 mm for PNA2108
5077 H-(KFF)3K-eg1- TA CTC T 6 acpP
5079 H-(KFF)3K-eg1- C ATA CTC T 8 acpP
5080 H-(KFF)3K-eg1- TC ATA CTC T 9 acpP
2108 H-(KFF)3K-eg1- CTC ATA CTC T 10 acpP
5082 H-(KFF)3K-eg1- G CTC ATA CTC T 11 acpP
5083 H-(KFF)3K-eg1- TG CTC ATA CTC T 12 acpP
5164 H-(KFF)3K-eg1- A GTG CTC ATA CTC T 14 acpP
5166 H-(KFF)3K-eg1- ATA GTG CTC ATA CTC T 16 acpP
5168 H-(KFF)3K-eg1- CG ATA GTG CTC ATA CTC T 18 acpP
5396 H-(KFF)3K-eg1- TAC ACT 6 mm for PNA5077
5270 H-(KFF)3K-eg1- CT TAC ACT 8 mm for PNA5079
5271 H-(KFF)3K-eg1- TCT TAC ACT 9 mm for PNA5080
5272 H-(KFF)3K-eg1- C TCT TAC ACT 10 mm for PNA2108
5273 H-(KFF)3K-eg1- GC TCT TAC ACT 11 mm for PNA5082
5274 H-(KFF)3K-eg1- TGC TCT TAC ACT 12 mm for PNA5083
5404 H-(KFF)3K-eg1- AG TGC TCT TAC ACT 14 mm for PNA5164
5406 H-(KFF)3K-eg1- A TAG TGC TCT TAC ACT 16 mm for PNA5166
5408 H-(KFF)3K-eg1- CGA TAG TGC TCT TAC ACT 18 mm for PNA5168
3986 H-(R-Ahx)6-(β-Ala)- CTC ATA CTC T 10 acpP
4227 H-(R-Ahx)6-(β-Ala)- TG CTC ATA CTC T 12 acpP
4228 H-(R-Ahx)6-(β-Ala)- A GTG CTC ATA CTC T 14 acpP
4229 H-(R-Ahx)6-(β-Ala)- ATA GTG CTC ATA CTC T 16 acpP
4230 H-(R-Ahx)6-(β-Ala)- CG ATA GTG CTC ATA CTC T 18 acpP
3987 H-(R-Ahx)6-(β-Ala)- C TCT TAC ACT 10 mm for PNA3986
4500 H-(R-Ahx)6-(β-Ala)- TGC TCT TAC ACT 12 mm for PNA4227
4501 H-(R-Ahx)6-(β-Ala)- AG TGC TCT TAC ACT 14 mm for PNA4228
4502 H-(R-Ahx)6-(β-Ala)- A TAG TGC TCT TAC ACT 16 mm for PNA4229
4503 H-(R-Ahx)6-(β-Ala)- CGA TAG TGC TCT TAC ACT 18 mm for PNA4230
4099 H-(R-Ahx-R)4-Ahx-(β-Ala)- CTC ATA CTC T 10 acpP
4246 H-(R-Ahx-R)4-Ahx-(β-Ala)- TG CTC ATA CTC T 12 acpP
4247 H-(R-Ahx-R)4-Ahx-(β-Ala)- A GTG CTC ATA CTC T 14 acpP
4248 H-(R-Ahx-R)4-Ahx-(β-Ala)- ATA GTG CTC ATA CTC T 16 acpP
4288 H-(R-Ahx-R)4-Ahx-(β-Ala)- CG ATA GTG CTC ATA CTC T 18 acpP
5631 H-(KFF)3K-eg1-Cys(BODIPY)- TA CTC T 6 acpP
5491 H-(KFF)3K-Cys(BODIPY)- CTC ATA CTC T 10 acpP
5629 H-(KFF)3K-eg1-Cys(BODIPY)- A GTG CTC ATA CTC T 14 acpP
The PNAs were synthesized as previously reported (Good et al., 2001; Ghosal et al., 2013). eg1, 8-amino-3,6-dioxaoctanoic acid; Ahx, 6-aminohexanoic acid; Cys,
cysteine; BODIPY, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene. Underlined: 10 nucleobase common motif. Bold and underlined: mismatched nucleobases.
Frontiers in Microbiology | www.frontiersin.org 3 May 2019 | Volume 10 | Article 1032
fmicb-10-01032 May 22, 2019 Time: 17:2 # 4
Goltermann et al. Antisense PNA-Peptide Antibacterials Length Dependence
TABLE 2 | MIC-values.
(KFF)3K PNA5079 8-mer PNA5080 9-mer PNA2108 10-mer PNA5082 11-mer PNA5083 12-mer
Match mm Match mm Match mm Match mm Match mm
MG1655 4 16 2–4 16 0.5–1 16 4 16 4 16
MG1655(1sbmA) 16 16–32 16 16 8–16 16–32 16 16 16 16
AS19 0.5 2 0.5 2 0.125 1–2 0.5 2 0.5 2
ATCC25922 (1rfaG) 0.25 >8 nd nd 0.125 4 >0.25 >1 1–2 1–2
Klebsiella pneumoniae 8–16 >32 nd nd 2 >32 nd nd 8 >32
MIC values (µM) of 8–12-mer match or mismatch (italicized) anti-acpP PNA conjugate. nd, Not determined.
RESULTS
MIC-PNA Length Relation of
(KFF)3K-PNA Conjugates
Exploiting the most commonly used E. coli gene target
as well as delivery BPP, the antimicrobial effect of a
series of 8–18 mer (KFF)3K-PNA conjugates against the
acpP target in E. coli as well as the Tm of their duplexes
with complementary RNA was determined (Table 2 and
Supplementary Figure S1). The results (Figure 1A)
revealed a direct correlation between antimicrobial activity
and Tm for PNAs shorter than 10 nucleobases, while a
reverse correlation was seen for PNAs longer than 10,
thus showing an activity optimum at 10 nucleobases
against E. coli MG1655 in agreement with previous reports
(Good et al., 2001; Deere et al., 2005). Importantly, when
analogous mismatch PNA constructs were tested, low
activity and no length dependence was found (Table 2
and Supplementary Figure S2); thus corroborating the
conclusion that the antimicrobial activity is indeed caused
by an antisense mechanism of action also for the PNAs of
different lengths. This observation extended to Klebsiella
pneumonia (Table 2) in which the acpP sequence target is
conserved demonstrating that the length constraint is not
limited to E. coli.
Correlation Between PNA–RNA Duplex
Stability and Antibacterial Activity
From the results of a previous sequence target optimization
study, a general relationship between antibacterial efficacy and
PNA–DNA duplex stability was not apparent (Dryselius
et al., 2003). However, due to confounding effects of
mRNA target position, a direct comparison of these two
parameters requires the location of the mRNA target to
remain constant while only changing the antisense oligomer
(e.g., in terms of nucleobase sequence). By introducing
single mismatches at different positions in a well-described
antisense peptide-PNA conjugate, and exploiting the differential
effect of mismatch position on duplex destabilization, we
interrogated the correlation between PNA/RNA affinity,
as measured by thermal melting, and the antimicrobial
effect of the PNA. In this case a clear, direct correlation
between PNA/RNA duplex stability (melting temperature)
and the antisense efficacy (as measured by MIC) was
observed (Figure 1B and Supplementary Table S1) (except
for one outlier, which must be caused by an unexplained
biological effect). Therefore the above described effect of
PNA length on antibacterial activity (Figure 1A) follows the
expected duplex stability between 8 and 10 nucleobases, but
reverses above 10 nucleobases. Consequently, the decreasing
activity as the PNA is extended beyond 10 nucleobases
must be due to another phenomenon, of which length
dependent decreased uptake would be an obvious candidate,
as previously proposed but not experimentally supported
(Good et al., 2001).
PNA Length Effects in Envelope Mutants
The length dependence was also studied in E. coli AS19 and
1rfaG, which because of a compromised LPS barrier are
inherently more sensitive toward antisense PNAs, and antibiotics
in general (Good and Nielsen, 1998). The AS19 strain has a
not fully characterized truncated LPS structure (Sekiguchi and
Iida, 1967), while the 1rfaG strain lacks the entire outer LPS
core (Ebbensgaard et al., 2018). Similar to the results obtained
with the MG1655 strain, the (KFF)3K-PNA with a PNA-length of
10 nucleobases showed the lowest MIC value, and any decrease
or increase in PNA-length reduced the growth inhibitory effect
of the (KFF)3K-PNA (Table 2). This suggests that the inner
membrane (or the peptidoglycan cell wall) is a significant
contributor to the length constraints. In order to eliminate the
effect of the carrier peptide, we also tested the length dependence
FIGURE 1 | Thermal stability of PNA–RNA duplex correlates with MIC-value.
(A) MIC and melting temperature for (KFF)3K-PNAs of increasing PNA length.
(B) Correlation between melting temperature and MIC for (KFF)3K-PNA with
single base mismatches.
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TABLE 3 | MIC-values.
Naked PNA PNA2301 10-mer PNA4223 12-mer PNA4224 14-mer
AS19 2 >32 4 16 32 >32
MIC values (µM) of 10–14-mer match or mismatch (italicized) anti-acpP
PNA in AS19.
of naked PNA in the AS19-strain. Increasing the PNA length
from 10- to 12- and 14-mer reduced activity in AS19 (Table 3 and
Supplementary Figure S3), indicating that even without a carrier
peptide, increasing the PNA length impairs antibacterial efficacy.
Effect of the SbmA Transporter
The antibacterial activity of (10-mer) (KFF)3K-PNA is dependent
on the inner membrane transporter SbmA for activity (Ghosal
et al., 2013). Therefore, a reduced uptake of longer PNAs
could be due to length (size) limiting transport efficacy of
SbmA. As expected, none of the (8- to 12-mers) (KFF)3K-
PNAs exhibited any antisense related antibacterial activity
in the MG1655(1sbmA) strain since match and mismatch
compounds showed no significant difference in MIC values
(Table 2). However, it has previously been demonstrated that
the (KFF)3K-peptide can be substituted with other peptides
[such as H-(R-Ahx)6-(β-Ala) or H-(R-Ahx-R)4-Ahx-(β-Ala)]
resulting in PNA conjugates that do not require SbmA for
bacterial uptake (Ghosal et al., 2013; Hansen et al., 2016).
Thus, we investigated whether the length effect was limited
to the (KFF)3K peptide by measuring the MIC values of
the anti-acpP-PNA conjugated to the H-(R-Ahx)6-(β-Ala) or
the H-(R-Ahx-R)4-Ahx-(β-Ala) peptide, respectively. Again,
exceeding a PNA length of 10 nucleobases reduced the MIC
value significantly (Table 4), indicating that this effect is
not limited to the (KFF)3K-PNA conjugate. Combined, these
results suggest that PNA length is important for transport
through SbmA as well as for transport via an SbmA-
independent pathway.
Effect of PNA on E. coli Spheroplasts
In an effort to completely abolish any contribution of the
outer membrane, the effect of anti-acpP-PNAs of different
lengths on E. coli spheroplasts revival was measured.
Spheroplasts were isolated and incubated with peptide-
PNA conjugates of different lengths, and survivors were
determined by plating (Figure 2). The 10-mer was clearly the
FIGURE 2 | Uptake of PNA is limited by the inner membrane in E. coli
spheroplasts. Survival of E. coli spheroplasts after incubation with
peptide-PNA conjugates (A,B) of different PNA length.
most efficient in reducing bacterial survival among the 6-,
10- and 14-mer (KFF)3K-PNAs (Figure 2A). Analogously,
the 10-mer H-(R-Ahx-R)4-Ahx-(β-Ala)-PNA showed higher
activity than the longer PNAs (Figure 2B), and a reverse
activity/length relation was seen in line with the data obtained
with intact cells.
Determination of Peptide-PNA Uptake by
Flow Cytometry
In order to physically monitor the uptake of the peptide-PNA-
conjugates of different PNA length, we constructed BODIPY-
labeled variants, which could be traced using flow cytometry.
Although inclusion of fluorophores generally hampers cellular
activity (increases MIC) (unpublished results), the 10-mer
retained higher activity compared to the 6-mer and 14-
mer, respectively (Figure 3). Although the major part of the
bacterial population contained only a limited amount of PNA
(Figure 3A), a fraction with a very significant uptake of the
green BODIPY-labeled PNA could be detected as a tail of
higher fluorescence on the histogram (Figure 3B). Similar
population heterogeneity of uptake at low concentration of
antimicrobial peptides has previously been reported (Pérez-
Peinado et al., 2018). Analyzing the fraction of green cells
reveals a reverse correlation between the PNA length and
bacterial cellular uptake, although the conjugates containing
the 6-mer and 14-mer PNA show similar activity (MIC).
TABLE 4 | MIC values (µM) of H-(R-Ahx)6-(β-Ala)-PNA and H-(R-Ahx-R)4-Ahx-(β-Ala)-PNA from 10-mer to 18-mer.
H-(R-Ahx-R)4-Ahx-(β-Ala)- PNA3986 10-mer PNA4227 12-mer PNA4228 14-mer PNA4229 16-mer PNA4230 18-mer
MG1655 1–2 8 >32 >32 >32
MG1655(1sbmA) 1 4 >32 >32 >32
AS19 0.5/2∗ 1/1–2∗ 2/nd∗ 2/2∗ 2/2–4∗
H-(R-Ahx)6-(β-Ala)- PNA4099 10-mer PNA4246 12-mer PNA4247 14-mer PNA4248 16-mer PNA4288 18-mer
MG1655 1 8 >16 >16 >16
MG1655(1sbmA) 1 4 >32 >32 >32
∗Mismatch PNA.
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FIGURE 3 | Peptide-PNA uptake monitored by flow cytometry. E. coli culture incubated with BODIPY fluorophore labeled peptide-PNA with different PNA length was
profiled by flow cytometry. (A) Full profiles of E. coli cultures incubated with each of the three peptide-PNA conjugates or without PNA. Background fluorescence
extends to approx. 130 fluorescence units. (B) Excerpt from (A, box) showing only the part of the bacterial population containing the labeled
peptide-PNA-conjugate. (C) Percentage of bacterial cells with peptide-PNA uptake.
Thus by compensating for the different uptake efficiency, a
very rough estimate of the intracellular efficacy of the 6-, 10-
and 14-mer PNA indicates a 1:3:10 ratio between these. This
supports the hypothesis that longer PNAs are less efficiently
taken up thereby limiting their otherwise higher intrinsic
potency, and that the optimum for a 10-mer PNA reflects
a balance between cellular uptake efficiency and intrinsic
antisense activity.
DISCUSSION
Uptake of antimicrobial agents through the Gram-negative
outer membrane is determined by their size, symmetry and
hydrophobicity. In general, small ( < 600 Da) hydrophilic
or amphiphilic molecules, such as beta-lactams and some
quinolones, penetrate the outer membrane through porins
(Hancock and Bell, 1988; Nikaido, 2003), while certain larger
antibiotics may be able to enter through nutrient transporters
(Braun et al., 2001).
Larger and more hydrophobic compounds (e.g.,
aminoglycosides) are generally taken up much slower
through a self-promoted pathway in which the compounds
accumulate on the cell surface until reaching a critical
concentration at which, pores form in the outer membrane
allowing a surge of antibiotic to enter (Hancock and Bell, 1988;
Richter and Hergenrother, 2019).
Other compounds, such as the bacteriocins enter by an
energy dependent pathway using the tolA or tonB systems
(Nikaido, 2003). Highly hydrophobic compounds are usually
ineffective against Gram-negatives except for deep rough mutants
in which these antibiotics can diffuse through the lipid
bilayer, also known as the hydrophobic pathway (Nikaido,
1976; Hancock and Bell, 1988). Furthermore, perturbation
of the LPS-layer such as that found in rough or deep-
rough mutants generally increases the sensitivity toward
hydrophobic antibiotics while reducing the sensitivity to selected
hydrophilic antibiotics, probably because of rearrangement
of the membrane and reduction of the number of porins
(Sen and Nikaido, 1991).
The PNA-peptide conjugates having masses of around 5 kDa
are significantly larger than conventional antibiotics and also
somewhat larger than most naturally derived antimicrobial
peptides. It is therefore unlikely that porins are involved in
transport over the outer membrane. This is supported by the
fact that no porin mediated resistance mechanisms have yet been
identified for PNA-peptide conjugates.
The BPP-PNAs differ from membrane-disruptive cationic
antimicrobial peptides by having a cytoplasmic target and
therefore must also cross the peptidoglycan cell wall and
the inner membrane. Other antibiotic classes such as the
aminoglycosides, the macrolides and some quinolones
are most likely sufficiently hydrophobic to pass through
the inner membrane by passive diffusion, and the cell
wall appears permeable for particles up to at least 2 nm
(Demchick and Koch, 1996). Hydrophilic molecules such as
most antimicrobial peptides with intracellular targets utilize
transporters in the inner membrane for translocation (such as
SbmA) (Paulsen et al., 2016). We have previously described
a similar mechanism for certain peptide-PNA conjugates,
which do exploit the SbmA-transporter for passage. For PNAs
conjugated to arginine-rich carrier peptides, however, it remains
unclear how the inner membrane is traversed. No porin or
transporter mutants have yet been identified, which could
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provide resistance toward PNAs conjugated to arginine-rich
peptides. This suggests that no single non-essential gene product
is responsible for the uptake and/or that multiple pathways
exist for entry into the cytoplasm for these compounds, and
the mechanism may rely on local disturbance/disruption of the
lipid bilayer. Finally, it is unlikely that the peptidoglycan cell
wall constitutes a size barrier for the longer PNA conjugates,
as particles of 2 nm, i.e., much wider than the diameter
of the PNA oligomer, transverse freely through the cell wall
(Demchick and Koch, 1996).
CONCLUSION
The present results clearly show that antisense potency of PNA-
peptide conjugates in E. coli exhibits an optimum around a target
size of 10 nucleobases, and that this optimum is due to opposing
PNA length effects on mRNA binding affinity versus efficiency
of bacterial uptake. Interestingly, the size-limited uptake is
independent of the delivery peptide and the data indicates that
the size limitation may predominantly be ascribed to restrictions
of inner membrane passage. Thus further studies elucidating the
detailed molecular mechanism for bacterial uptake is warranted
in order to understand the details of the uptake mechanism
as well as to facilitate rational approaches for design of novel
delivery vehicles that may relax this size-limitation thereby
allowing the development of longer and thus higher potency
bacterial antisense agents.
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